AI Mood Market: Stock Dashboard

Company: Zenas Biopharma Inc

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: NASD

Index: RUT

P/E: -

EPS (ttm): -

Insider Own: 76.39%

Shs Outstand: 41.78M

Perf Week: 13.31%

Market Cap: 387.82M

Forward P/E: -

EPS next Y: -

Insider Trans: 18.13%

Shs Float: 11.32M

Perf Month: -14.47%

Income: -

PEG: -

EPS next Q: -1.00

Inst Own: 25.80%

Short Float: 18.82%

Perf Quarter: -47.54%

Sales: -

P/S: -

EPS this Y: -

Inst Trans: -

Short Ratio: 7.00

Perf Half Y: -

Book/sh: 8.60

P/B: 1.08

EPS next Y Percentage: -

ROA: -

Short Interest: 2.13M

Perf Year: -

Cash/sh: 9.26

P/C: 1.00

EPS next 5Y: -

ROE: -

52W Range From: 7.79

52W Range To: 26.25

Perf YTD: 13.31%

Dividend Est.: -

P/FCF: -

EPS past 5Y: -

ROI: -

52W High: -64.65%

Beta: -

Dividend TTM: -

Quick Ratio: 8.95

Sales past 5Y: 0.00%

Gross Margin: -

52W Low: 19.13%

ATR (14): 1.16

Dividend Ex-Date: Dec 24, 2019

Current Ratio: 8.95

EPS Y/Y TTM: -

Oper. Margin: -

RSI (14): 41.15

Volatility W: 12.91%

Volatility M: 10.61%

Employees: -

Debt/Eq: 0.00

Sales Y/Y TTM: -

Profit Margin: -

Recom: 1.00

Target Price: 34.33

Option/Short: No / Yes

LT Debt/Eq: 0.00

EPS Q/Q: -21.88%

Payout: -

Rel Volume: 0.67

Prev Close: 9.77

Sales Surprise: -

EPS Surprise: -427.92%

Sales Q/Q: -

Earnings: Nov 12 BMO

Avg Volume: 304.35K

Price: 9.28

SMA20: -1.52%

SMA50: -30.43%

SMA200: -40.44%

Trades:

Volume: 204,722

Change: -5.02%

AI Market Mood: Stock Dashboard

ZBIO

Fundamental

Technical:

Latest News:

Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 million valuation in US IPO somewhat bullish

ZBIO